These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2688720)

  • 1. Renal transplantation: results in hemodialysis patients previously treated with recombinant human erythropoietin.
    Paganini EP; Braun WE; Latham D; Abdulhadi MH
    ASAIO Trans; 1989; 35(3):535-8. PubMed ID: 2688720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin correction of anemia. Dialysis efficiency, waste retention, and chronic dose variables.
    Paganini EP; Abdulhadi MH; Garcia J; Magnusson MO
    ASAIO Trans; 1989; 35(3):513-5. PubMed ID: 2688718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialyzer urea and creatinine clearances are not significantly altered in erythropoietin treated maintenance hemodialysis patients.
    Delano BG; Lundin AP; Galonsky R; Quinn-Cefaro RM; Rao TK; Friedman EA
    ASAIO Trans; 1990; 36(1):36-9. PubMed ID: 2306389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
    Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effects of recombinant human erythropoietin in hemodialysis patients. Results of the "Abruzzo" Multicenter Trial.
    Di Paolo B; Di Liberato L; Summa R; Catucci G; Del Rosso G; Muscianese P; Albertazzi A
    ASAIO Trans; 1991; 37(3):M380-1. PubMed ID: 1751197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of renal transplantation in patients treated with erythropoietin.
    Linde T; Wahlberg J; Wikström B; Danielson BG
    Clin Nephrol; 1992 May; 37(5):260-3. PubMed ID: 1606776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human erythropoietin on vascular access.
    Dy GR; Bloom EJ; Ijelu GK; Merritts GW; Kramer MS; Raja RM
    ASAIO Trans; 1991; 37(3):M274-5. PubMed ID: 1751146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The observation of therapy of anemia in chronic renal failure with recombinant human erythropoietin].
    Jiang Y; Liu P; Wang EJ
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):80-2. PubMed ID: 8070295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ergometric results of r-erythropoietin treatment of hemodialysis patients].
    Hortian B; Schmidt R; Wüstenberg PW; Dörp E; Schumann L; Winkler R; Klinkmann H
    Z Gesamte Inn Med; 1990 May; 45(10):274-7. PubMed ID: 2392856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
    Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human erythropoietin on renal function in humans.
    Lim VS; Fangman J; Flanigan MJ; DeGowin RL; Abels RT
    Kidney Int; 1990 Jan; 37(1):131-6. PubMed ID: 2299799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical considerations of recombinant human erythropoietin therapy.
    Paganini EP; Latham D; Abdulhadi M
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):19-25. PubMed ID: 2667348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the efficacy and tolerance of recombinant human erythropoietin between intravenous and subcutaneous administration in chronic hemodialysis. Prospective multicenter study].
    Ruedin P; Stoerman C; Pechère-Bertschi A; Leski M
    Nephrologie; 1992; 13(2):87-92. PubMed ID: 1608502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.